The global research antibodies market is projected to be worth USD 5,325.8 Million by 2027, according to a current analysis by Emergen Research. The market is estimated to register a CAGR of 5.9% from 2020 to 2027. Rising application areas for research antibodies and the high demand for personalized medicines are expected to propel the growth of this market over the forecast period.
Research antibodies have become important tools in biomedical research as they can be used to detect and quantify proteins, detect mutations, and study protein-protein interactions. They are also used in therapeutic applications such as cancer immunotherapy and have a wide range of applications in the field of diagnostics. The growing demand for research antibodies from the pharmaceutical and biotechnology industries is expected to fuel the growth of this market over the forecast period.
The rising prevalence of chronic diseases such as cancer and autoimmune diseases is expected to drive the growth of the research antibodies market. According to the World Health Organization (WHO), the global burden of cancer is expected to rise by about 70% over the next two decades. The number of new cancer cases is expected to increase from 14 million in 2012 to 22 million by 2032. The increasing prevalence of chronic diseases is expected to boost the demand for research antibodies for therapeutic applications.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/192
The high cost of research antibodies and the lack of standardization are major factors restraining the growth of this market. The high cost of research antibodies is a major barrier to their adoption in developing countries. In addition, the lack of standardization in terms of quality and specifications is another major challenge faced by the market.
Some Key Highlights from the Report
- Heavy investments in research and development activities by leading companies are projected to fuel the growth of the global research antibodies market. For instance, in July 2019, Merck KGaA (Germany) launched three new products, which included a total of 12 monoclonal antibodies. The company has been focusing on expanding its product portfolio through strategic collaborations and launches of innovative products.
- In January 2020, a leading market player, Abcam PLC, announced the acquisition of Novus Biologicals, based in the US. This move is aimed at strengthening its foothold in the global market for research antibodies. The acquisition is also expected to provide Abcam with a greater range of high-quality antibodies and ELISA kits, enabling it to better serve researchers working on targets across a wide variety of therapeutic areas.
- In terms of value, the monoclonal segment dominated the global research antibodies market in 2016 and is expected to grow at a CAGR of 5.4% during the forecast period. Monoclonal antibodies are used in research applications as marker proteins, target protein interaction studies, ELISA-based detection methods, blotting techniques, protein isolation & purification, and cell proliferation & cell death analysis. The segment is also used in therapeutic applications such as cancer and autoimmune diseases.
- The polyclonal segment of the global research antibodies market is expected to grow at the highest CAGR during the forecast period. Polyclonal antibodies are used for detection and isolation of proteins, ELISA-based detection methods, blotting techniques, and cell proliferation & cell death analysis.
- The primary antibodies segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing demand for primary antibodies from various end users, such as research laboratories and pharmaceutical and biotechnology companies.
- The oncology segment is projected to grow at the highest CAGR in the global research antibodies market during the forecast period. The large share and high growth of this segment can be attributed to factors such as rising number of cancer incidences, development of innovative antibody products for cancer treatment, and government initiatives to increase cancer awareness.
- North America is expected to account for the largest share of the research antibodies market in 2017. The region’s large share of this market can be attributed to factors such as well-established research and development facilities, availability of advanced healthcare infrastructure, and growing funding for research activities.
- The Asia Pacific region is expected to witness the highest growth rate over the forecast period. The increasing number of pharmaceutical and biotechnology companies in China, India, and Japan is expected to drive the growth of this market in the region. In addition, the growing awareness about the benefits of research antibodies is expected to further boost the growth of this market in the Asia Pacific region.
- Key participants include Lonza Group, Becton, Dickinson and Company, Agilent Technologies, Bio-Rad Laboratories, Abcam PLC, PerkinElmer, Inc., Thermo Fisher Scientific, Merck Millipore, F.Hoffmann-La Roche AG, and Cell Signaling Technology Inc., among others.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/research-antibodies-market
Emergen Research has segmented the global research antibodies market on the basis of antibody type, product, application, technology, end-users, and region:
Antibody Type Outlook (Revenue, USD Million; 2017-2027)
Product Outlook (Revenue, USD Million; 2017-2027)
- Primary Antibodies
- Secondary Antibodies
Application Outlook (Revenue, USD Million; 2017-2027)
- Infectious Diseases
- Stem Cells
Technology Outlook (Revenue, USD Million; 2017-2027)
- Western Blotting
- Flow Cytometry
- Enzyme-linked Immunosorbent Assay
End-Users Outlook (Revenue, USD Million; 2017-2027)
- Pharmaceutical & Biopharmaceutical Firms
- Academic & Research Institutes
- Contract Research Organizations
Regional Outlook (Revenue, USD Million; 2019-2030)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- North America
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/192
Explore More Reports Emergen Research:
Business intelligence and analytics market
Radiation Therapy Quality Assurance (QA) Phantom Market
Advanced Prostheses and Exoskeletons Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-research-antibodies-market